Navigation Links
UAB professor receives HudsonAlpha Innovation Prize
Date:5/8/2009

Huntsville, Ala. Dr. Casey Weaver, University of Alabama at Birmingham professor of pathology, has been awarded the 2009 HudsonAlpha Prize for Outstanding Innovation in Life Sciences. The prize, which includes a $20,000 cash award, salutes Weaver's achievements in advancing understanding of immune protection and immune disease through T cell research.

According to Weaver, our bodies use T cells to protect against infections and cancer, but when T cells overreact and turn on the body, we see immune-mediated diseases such as rheumatoid arthritis, inflammatory bowel disease, lupus and multiple sclerosis. "Our studies have contributed to the identification of a new class of T cells, called Th17 cells, which are now recognized as important participants in a growing number of autoimmune diseases," said Weaver.

"By understanding how this class of T cells develops and functions in normal and abnormal immunity, we hope to identify new approaches to curb these cells' destructive potential as a means to treat patients who suffer from certain types of autoimmune disease and perhaps harness this potential to eradicate certain types of infections and malignancies," he added.

The prize, in addition to recognizing exceptional talent and research of superior merit, aims to raise awareness of Alabama's growing life sciences community. Presidents of Alabama's six public research universities could nominate up to two teams or individual candidates from their respective institutions.

Dr. Richard Myers, HudsonAlpha Institute for Biotechnology president and director, presented the award. Myers acknowledged the pool of nominees reflected the high quality of scientific investigation that is ongoing at Alabama's research universities.

The HudsonAlpha prize committee received its recommendations from a distinguished and impartial group of scientists who reside outside the state and who have no connections to participating universities.'/>"/>

Contact: Holly Ralston McClain
hmcclain@hudsonalpha.org
256-327-0425
HudsonAlpha Institute for Biotechnology
Source:Eurekalert

Page: 1 2

Related biology news :

1. From cars to cancer: UH professor employs auto industry tools for tumor therapy
2. UC Riverside professor receives top scientific honor
3. Boston College chemistry professor Udayan Mohanty receives a 2009 Guggenheim Fellowship
4. Image processing and mathematical morphology in new text by NJIT professor
5. Hebrew University professors work leads to FDA approval for product
6. Professor to measure environmental impact of war
7. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
8. IADR Wilmer Souder Award presented to University of Colorado professor
9. UC San Diego bioengineering professor trey ideker wins 2009 Overton Prize
10. Evolution education for K-12 teachers needs beefing up, says CU-Boulder professor
11. British journal publishes inorganic chemistry research of NJIT professor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2015)... June 17, 2015  Crossmatch™, a leading provider ... its U.are.U ® 4500 fingerprint readers have ... Eateries, Inc., a San Jose, CA ... increase security, improve accountability and reduce fraud at ... non-repudiable identity confirmation for employee sign in and ...
(Date:6/16/2015)... 2015 Fingerprint Cards (FPC) raises the ... will amount to at least 340 MSEK to that it ... increase in market growth and orders received the revenue guidance ... revenue for 2015 will exceed 1,500 MSEK to an updated ... MSEK. Due to receipt of orders of touch ...
(Date:6/12/2015)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announced the United States Patent ... and identify participants of a video visitation session ... system can: , Identify that the ... process is actually the person participating in the ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... Researchers have gained a new understanding of the way ... can be slowed via angiogenesis inhibitors that eliminate the blood ... new anti-cancer drug therapies. The results of this study have ... American Journal of Pathology. "The central role of ...
... to define the roles of microRNAs is announced today ... gives researchers access to tools to investigate the biological ... genes. mirKO is a "library" of mutant mouse ... groups of microRNA genes, have been deleted. Using these ...
... 2011, Shenzhen, China BGI, the world,s largest genomics ... Hospital, announced today that the study on frequent mutations ... of the bladder was published online in Nature ... for future studies on TCC, suggesting that aberration of ...
Cached Biology News:Researchers gain new insights into how tumor cells are fed 2New resource to unlock the role of microRNAs 2New resource to unlock the role of microRNAs 3Research discovers frequent mutations of chromatin remodeling genes in TCC of the bladder 2
(Date:6/30/2015)... -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ), a specialty ... unmet medical needs in women,s health, today announced ... at the Cantor Fitzgerald Inaugural Healthcare Conference as ... PM EDTLocation: , Le Parker Meridien Hotel, New ... under  ,Investor, or  click here The ...
(Date:6/30/2015)... ... 30, 2015 , ... With its latest polyacrylonitrile (PAN) membrane, ... faster flow rates in comparison to nylon or polyethersulfone (PES). Its unique ... easy liquid flow while trapping particulates as small as 0.2 micron in width. ...
(Date:6/30/2015)... ... 2015 , ... Matrix Marketing Group, LLC , a leading provider of ... head up its account management department as vice president of client services. Amanda ... account management and delivery expertise to the growing Matrix Marketing Group team in Denver, ...
(Date:6/30/2015)... 30, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... its Phase 1/2 clinical trial of RCT-01, being ... tendinosis, has been enrolled and their tissue biopsy ... RCT-01 is comprised of non-bulbar dermal sheath (NBDS) ...
Breaking Biology Technology:Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2Matrix Marketing Group Expands Client Services Team 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4
... BEDFORD, Mass., Oct. 29 Aware, Inc. (Nasdaq:,AWRE), a ... that its Board of Directors has approved an extension ... repurchase from,time to time at management,s discretion up to ... in the open market or in private until December,31, ...
... Income Per Share, SAN JOSE, Calif., Oct. 29 ... leading provider of medical devices,for the minimally invasive treatment ... third quarter ended September 30, 2008., Net revenues ... $23.1,million compared with $17.5 million for the third quarter ...
... (OTC,Bulletin Board: TBIO) today announced financial results for the ... presented in,the tables that follow., Third Quarter 2008, ... during the third,quarter of 2008, compared to $5.2 million ... operations was $2.9 million or 54,percent during the third ...
Cached Biology Technology:Aware, Inc. Announces Extension of Stock Repurchase Plan 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 3VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 4VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 5VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 6VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 7VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 8VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 9VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 10Transgenomic, Inc. Reports Third Quarter 2008 Results 2Transgenomic, Inc. Reports Third Quarter 2008 Results 3Transgenomic, Inc. Reports Third Quarter 2008 Results 4Transgenomic, Inc. Reports Third Quarter 2008 Results 5Transgenomic, Inc. Reports Third Quarter 2008 Results 6Transgenomic, Inc. Reports Third Quarter 2008 Results 7
Form: Ready to use Applications: ELISA...
Form: Ready to use Applications: ELISA...
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble...
2,4,6, Trinitrophenyl hapten is conjugated to lipopolysaccharide (LPS)....
Biology Products: